`
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2036 Page 1
`
`
`
`
`
`"
`
`Handbook of
`
`PHARMACEUTICAL
`
`EXCIPIENTS
`
`
`
`Third Edition
`
`Edited by
`
`Arthur H. Kibbe, Ph.D.
`Professor and Chair
`Department of Pharmaceutical Sciences
`Wilkes University School of Pharmacy
`Wilkes-Barre, Pennsylvania
`
`302
`
`American Pharmaceutical Association
`Washington, D.C.
`
`(RP)
`
`Pharmaceutical Press
`
`London, United Kingdom
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2036 Page 2
`
`
`
`
`
`Published by the American Pharmaceutical Association
`2215 Constitution Avenue NW, Washington, DC 20037-2985, USA
`www.aphanet.org
`and the Pharmaceutical Press
`1 Lambeth High Street, London SE1 7JN, UK
`www.pharmpress.com
`
`© 1986, 1994, 2000 American Pharmaceutical Association and Pharmaceutical Press
`
`First edition 1986
`Second edition 1994
`Third edition 2000
`
`Printed in the United States of America
`
`ISBN: 0-85369-381—1 (UK)
`ISBN: O-917330-96-X (USA)
`
`Library of Congress Cataloging-in-Publication Data
`Handbook of pharmaceutical excipients / edited by Arthur H. Kibbe.—~3rd ed.
`p.
`; cm,
`Includes bibliographical references and index.
`ISBN 0-917330-96-X
`1. Excipients——Handbooks, manuals, etc.
`Pharmaceutical Association.
`[DNLMr 1. Excipients--Handbooks. QV 735 H236 2000]
`R8201.E87 H36 2000
`615'.l9—-dc21
`
`I. Kibbe, Arthur H. 11. American
`
`A catalogue record for this book is available from the British Library.
`
`99-044554
`
`All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or
`by any means, without the prior written permission of the copyright holder. The publisher makes no representation, express or
`implied, with regard to the accuracy of the information contained in this book and cannot accept any legal responsibility or
`liability for any errors or omissions that may be made.
`
`Managing Editor: Melanie Segala
`Copyeditor;
`Paul Gottehrer
`Indexer:
`Lillian Rodberg
`Compositor:
`Roy Barnhill
`Cover Designer:
`Tim Kaage
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2036 Page 3
`
`
`
`
`
`Contents
`
`v
`
`Contents
`
`Additions to the Third Edition
`Related Substances
`
`Acknowledgments
`Notice to Readers
`Selected Bibliography
`
`Units of Measurement
`
`Acesulfame Potassium
`
`Aliphatic Polyesters
`Alpha Tocopherol
`
`Ascorbyl Palmitate
`
`Benzalkonium Chloride
`Benzethonium Chloride
`
`Benzyl Alcohol
`Benzyl Benzoate
`
`Butylated Hydroxyanisole
`Butylated Hydroxytoluene
`
`Calcium Carbonate
`Calcium Phosphate, Dibasic Anhydrous
`Calcium Phosphate, Dibasic Dihydrate
`Calcium Phosphate, Tribasic
`Calcium Stearate
`Calcium Sulfate
`
`Carbon Dioxide
`Carboxymethylcellulose Calcium
`Carboxymethylcellulose Sodium
`
`Castor Oil, Hydrogenated
`Cellulose Acetate
`Cellulose Acetate Phthalate
`Cellulose, Microcrystalline
`Cellulose, Powdered
`Cellulose, Silicilied Microcrystalline
`Cetostearyl Alcohol
`
`Chlorodifluoroethane (HCFC)
`Chlorofluorocarbons (CFC)
`
`vii
`ix
`xii
`xiii
`xv
`xvii
`xviii
`xviii
`xix
`xx
`
`Cholesterol
`Citric Acid Monohydrate
`Colloidal Silicon Dioxide
`Coloring Agents
`Corn Oil
`Cottonseed Oil
`Cresol
`Croscarmellose Sodium
`Crospovidone
`Cyclodextrins
`Dextrates
`Dextrin
`Dextrose
`Dibutyl Sebacate
`Diethanolamine
`Diethyl Phthalate
`Difluoroethane (HFC)
`Dimethyl Ether
`Docusate Sodium
`Edetic Acid
`Ethylcellulose
`Ethyl Maltol
`Ethyl Oleate
`Ethylparaben
`Ethyl Vanillin
`Fructose
`Fumaric Acid
`Gelatin
`Glucose, Liquid
`Glycerin
`Glyceryl Monooleate
`Glyceryl Monostearate
`Glyceryl Palmitostearate
`Glycofurol
`Guar Gum
`Heptafluoropropane (HFC)
`Hydrocarbons (HC)
`Hydrochloric Acid
`Hydroxyethyl Cellulose
`Hydroxypropyl Cellulose
`Hydroxypropyl Cellulose, Low-substituted
`Hydroxypropyl Methylcellulose
`Hydroxypropyl Meth'ylcellulose Phthalate
`Imidurea
`Isopropyl Alcohol
`Isopropyl Myristate
`Isopropyl Palmitate
`Kaolin
`Lactic Acid
`Lactitol
`Lactose
`Lanolin
`Lanolin Alcohols
`Lanolin, Hydrous
`Lecithin
`Magnesium Aluminum Silicate
`Magnesium Carbonate
`Magnesium Oxide
`Magnesium Stearate
`Magnesium Trisilicate
`
`138
`140
`143
`146
`154
`156
`158
`160
`163
`1 65
`169
`172
`175
`178
`180
`182
`184
`186
`188
`191
`195
`201
`203
`205
`208
`210
`213
`215
`218
`220
`223
`225
`228
`230
`232
`234
`236
`238
`240
`244
`249
`252
`256
`261
`263
`265
`267
`269
`272
`274
`276
`286
`288
`290
`292
`295
`299
`303
`305
`309
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2036 Page 4
`
`
`
`vi Contents
`
`Malic Acid
`
`Maltitol Solution
`Maltodextrin
`
`Mannitol
`Medium Chain Triglycerides
`Megluruine
`
`,
`
`Methylcellulose
`Methylparaben
`Mineral Oil
`Mineral Oil, Light
`Mineral Oil and Lanolin Alcohols
`Monoethanolamine
`Nitrogen
`Nitrous Oxide
`Oleic Acid
`
`Peanut Oil
`Petrolatum
`Petrolatum and Lanolin Alcohols
`
`Phenoxyethanol
`Phenylethyl Alcohol
`Phenylmercuric Acetate
`Phenylmercuric Borate
`Phenylmercuric Nitrate
`Pol'acrilin Potassium
`Poloxamer
`PolydexIIose
`Polyethylene Glycol
`Polyethylene Oxide
`Polymethacrylates
`Polyoxyethylene Alkyl Ethers
`Polyoxyethylene Castor Oil Derivatives
`Polyoxyethylene Sorbitan Fatty Acid Esters
`Polyoxyethylene Stearates
`Polyvinyl Alcohol
`Potassium Chloride
`Potassium Citrate
`Potassium Sorbate
`Povidone
`Propylene Carbonate
`Propylene Glycol
`Propylene Glycol Alginate
`Propyl Gallate
`Propylparaben
`Saccharin
`Saccharin Sodium
`Sesame Oil
`Shellac
`Sodium Alginate
`
`311
`313
`315
`317
`320
`322
`324
`329
`332
`334
`336
`340
`345
`347
`349
`350
`352
`354
`356
`358
`360
`362
`365
`367
`370
`372
`374
`377
`379
`383
`386
`389
`392
`399
`401
`407
`412
`416
`420
`424
`426
`429
`431
`433
`440
`442
`445
`447
`450
`454
`457
`460
`462
`465
`
`Sodium Ascorbate
`Sodium Benzoate
`Sodium Bicarbonate
`Sodium Chloride
`Sodium Citrate Dihydrate
`Sodium Cyclamate
`Sodium Lauryl Sulfate
`Sodium Metabisulfite
`Sodium Phosphate. Dibasic
`Sodium Phosphate, Monobasic
`Sodium Propionate
`Sodium Starch Glycolate
`Sodium Stearyl Fumarate
`Sorbic Acid
`Sorbitan Esters (Sorbitan Fatty Acid Esters)
`Sorbitol
`Soybean Oil
`Starch
`Starch, Pregelatinized
`Starch, Sterilizable Maize
`Stearic Acid
`Stearyl Alcohol
`Sucrose
`Sugar, Compressible
`Sugar, Confectioner’s
`Sugar Spheres
`Suppository Bases, Hard Fat
`Talc
`Tartaric Acid
`Tetrafluoroethane (HFC)
`Thimcrosal
`Titanium Dioxide
`Tragacanth
`Triacetin
`Triethanolamine
`Triethyl Citrate
`Vanillin
`
`Vegetable Oil, Hydrogenated, Type I
`Water
`Wax, Anionic Emulsifying
`Wax, Carnauba
`Wax. Cetyl Esters
`Wax, Microcrystalline
`Wax, Nonionic Emulsifying
`Wax, White
`Wax, Yellow
`Xanthan Gum
`Xylitol
`Zein
`Zinc Stearate
`
`Appendix I: Suppliers’ Directory
`Appendix H: HPE Laboratory Methods
`Index
`
`468
`471
`474
`478
`
`482
`485
`487
`490
`493
`496
`498
`501
`505
`508
`511
`515
`519
`522
`528
`531
`534
`537
`539
`544
`546
`548
`550
`555
`558
`560
`562
`565
`568
`570
`572
`574
`576
`578
`580
`585
`587
`589
`591
`593
`595
`597
`599
`602
`606
`608
`
`611
`641
`645
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2036 Page 5
`
`
`
`
`
`xviii Notice to Readers
`
`
`
`
`
`Notice to Readers
`
`Selected Bibliography
`
`The Handbook of Pharmaceutical Excipients is a reference
`work containing a compilation of information on the uses and
`properties of pharmaceutical excipients and the reader is as—
`sumed to possess the necessary knowledge to interpret
`the
`information the Hdndbook contains. The Handbook has no
`official status and there is no intent, implied or otherwise,
`that any of the information presented should constitute stan-
`dards for the substances. The inclusion of an excipient in the
`Handbook, or a description of its use in a particular applica-
`tion, is not intended as an endorsement of that excipient or
`application. Similarly, reports of incompatibilities or adverse
`reactions to an excipient, in a particular application, may not
`necessarily prevent its use in other applications. Formulators
`should perform suitable experimental studies to satisfy them—
`selves and regulatory bodies that a formulation is efficacious
`and safe to use.
`
`While considerable efforts were made to ensure the accuracy
`of the information presented in the Handbook neither the pub-
`lishers nor the compilers can accept liability for any errors
`or omissions. In particular, the inclusion of a supplier within
`the Suppliers’ Directory is not intended as an endorsement of
`that supplier or its products and similarly the unintentional
`omission of a supplier or product from the directory is not
`intended to reflect adversely on that supplier or its product.
`
`Although diligent effort was made to use as recent compendia]
`information as possible, compendia are frequently revised and
`the reader is urged to consult current compendia, or supple-
`ments, for up—to-date information, particularly 'as efforts are
`currently in progress to harmonize standards for excipients.
`
`The laboratory data presented for a particular excipient re—
`flects only the results of testing a particular batch or sample
`and may not be representative of other batches or samples.
`
`Relevant data and constructive criticism are welcome and may
`be used to assist in the preparation of any- future editions of
`the Handbook. The reader is asked to send any comments to
`the Editor, Handbook of Pharmaceutical Excipients; Royal
`Pharmaceutical Society of Great Britain,
`1 Lambeth High
`Street, London SE1 7JN, UK, or Editor, Handbook of Phar-
`maceutical Excipients, American Pharmaceutical Association,
`2215 Constitution Avenue, NW, Washington, DC 20037-2985.
`
`A selection of publications which contain information on phar-
`maceutical excipients is listed below:
`
`Banker GS, Rhodes CT, editors. Modern Pharmaceutics, 2nd edi-
`tion. New York, Marcel Dekker Inc., 1990.
`British Pharmacopoeia 1998. London, The Stationery Office,
`1998.
`Budavari S, editor. The Merck Index: An Encyclopedia of Chem-
`icals, Drugs, and Biologicais, 12th edition. Whitehouse Sta-
`tion, NJ. Merck & Co., Inc., 1996.
`European Pharmacopoeia, 3rd edition and supplements. Stras-
`bourg, Council of Europe, 1996.
`Florence AT, Salole EG, editors. Formulation Factors in Adverse
`Reactions. London, Butterworth & Co., Ltd., 1990.
`Food and Drug Administration. Inactive Ingredient Guide. Wash-
`ington, DC; FDA, 1996.
`:
`Food Chemicals Codex, 4th edition. Washington, DC, National
`Academy Press, 1996.
`Gennaro AR, editor. Remington: The Science and Practice ofPharmacy,
`19th edition. Easton, PA, Mack Publishing Co., 1995.
`Health and Safety Executive. EH40/98: Occupational exposure
`limits, 1998. Sudbury, Health and Safety Executive, 1998.
`Japan Pharmaceutical Excipients Council. Japanese Pharmaceu-
`tical Excipients 1993. Tokyo, Japan, Yakuji Nippo Ltd., 1994.
`Japanese Pharmacopeia, 13th edition. Tokyo, Japan, Yakuji
`Nippo, Ltd., 1996.
`Lewis RI, editor. Sax‘s Dangerous Properties of Industrial Mate-
`rials, 9th edition. New York, Van Nostrand Reinhold, 1996.
`Lund W, editor. The Pharmaceutical Codex: Principles and Prac-
`tice of Pharmaceutics, 12th edition. London, Pharmaceutical
`Press, 1994.
`Parfitt K, editor. Martindale: The Complete Drug Reference, 32nd
`edition. London, Pharmaceutical Press, 1999.
`Smolinske SC. Handbook of Food, Drug and Cosmetic Excipi-
`ents. Boca Raton, FL, CRC Press Inc., 1992.
`Swarbrick I, Boylan J, editors. Encyclopedia of Pharmaceutical
`Technology, volumes 1-8. New York, Marcel Dekker Inc.,
`1988-1999.
`'
`Sweet DV, editor. Registry of Toxic Effects of Chemical Sub—
`stances. Cincinnati, US Department of Health, 1987.
`United States Pharmacopeia 24 and National Forrnulary 19 and
`Supplements. Rockville, MD, United States Pharmacopeial
`Convention, Inc., 2000.
`Weiner M, Bernstein IL. Adverse Reactions to Drug Formulation
`Agents: A Handbook of Excipients. New York, Marcel Dekker
`Inc., 1989.
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2036 Page 6
`
`